Raising Health
Mastering Data with Sajith Wickramasekara
Nov 12, 2024
Sajith Wickramasekara, CEO and co-founder of Benchling, transforms biotech workflows through innovative software solutions. He shares insights on the evolution of biotechnology and the crucial role of AI in drug discovery. Saji reveals how structured data can supercharge scientific research, addressing the challenges in integrating modern technology into pharma. He also discusses navigating competition and the startup journey, emphasizing the importance of understanding customer needs in a rapidly changing landscape.
26:45
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Sajith Wickramasekara's transition from engineer to Benchling co-founder highlights the transformative impact of tailored software in biotech innovation.
- The podcast underscores the critical importance of organized data and AI integration for enhancing drug discovery efficiency in the life sciences.
Deep dives
Transforming Biotech Through Innovation
Sajidh Wikramasakara's journey from a frustrated engineer in a biology lab to co-founder of Benchling illustrates the potential of innovative software in transforming the biotech industry. Twelve years ago, he recognized the inadequacy of existing tools for scientists and sought to create modern software tailored to their needs. This approach has propelled Benchling to serve over 200,000 scientists and more than 1,200 biopharma companies across 32 countries, generating over $200 million in annual revenue. Now, as the industry evolves, Benchling continues to sharpen its focus on digitizing and automating lab workflows, enabling researchers to streamline their processes and drive innovation in drug development.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
